New Hopes for Drugs against COVID-19 Come from the Sea

Mar Drugs. 2021 Feb 11;19(2):104. doi: 10.3390/md19020104.

Abstract

The latest chapter of the historic battle of humans against pathogenic microbes is the severe acute respiratory syndrome (SARS)-like coronavirus-2 (SARS-CoV-2), responsible for COVID-19, a respiratory disease declared a global pandemic by the WHO on March 11, 2020 [...].

Publication types

  • Editorial

MeSH terms

  • Anti-Inflammatory Agents / isolation & purification
  • Anti-Inflammatory Agents / pharmacology*
  • Anti-Inflammatory Agents / therapeutic use
  • Antimicrobial Cationic Peptides / isolation & purification
  • Antimicrobial Cationic Peptides / pharmacology
  • Antimicrobial Cationic Peptides / therapeutic use
  • Antiviral Agents / isolation & purification
  • Antiviral Agents / pharmacology*
  • Antiviral Agents / therapeutic use
  • Aquatic Organisms / chemistry*
  • Biological Products / isolation & purification
  • Biological Products / pharmacology*
  • Biological Products / therapeutic use
  • COVID-19 / epidemiology
  • COVID-19 / immunology
  • COVID-19 / prevention & control
  • COVID-19 / virology
  • COVID-19 Drug Treatment*
  • COVID-19 Vaccines / administration & dosage
  • Depsipeptides / isolation & purification
  • Depsipeptides / pharmacology
  • Depsipeptides / therapeutic use
  • Humans
  • Pandemics / prevention & control
  • Peptides, Cyclic / isolation & purification
  • Peptides, Cyclic / pharmacology
  • Peptides, Cyclic / therapeutic use
  • SARS-CoV-2 / drug effects
  • SARS-CoV-2 / immunology
  • Seawater / microbiology
  • Virus Attachment / drug effects

Substances

  • Anti-Inflammatory Agents
  • Antimicrobial Cationic Peptides
  • Antiviral Agents
  • Biological Products
  • COVID-19 Vaccines
  • Depsipeptides
  • Peptides, Cyclic
  • gallinamide A
  • plitidepsin